GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
WEB1 day ago · CNN —. GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced ...
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
WEB1 day ago · Oct 9 (Reuters) - GSK (GSK.L) has agreed to pay up to $2.2 billion to settle most pending U.S. state court lawsuits claiming that a discontinued version of the heartburn drug Zantac caused cancer ...
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
WEB1 day ago · Oct. 9, 2024. The British drug maker GSK said on Wednesday that it would pay up to $2.2 billion to settle most of the lawsuits filed against it by people who claim that they developed cancer after ...
Zantac maker GSK agrees to pay $2.3 bn in US settlements
WEB1 day ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
Pharma giant GSK to pay $2.2 to settle Zantac lawsuits - BBC
WEB1 day ago · UK firm GSK to pay $2.2bn over Zantac cancer claims. Getty Images. GSK has reached agreements with law firms representing around 80,000 claimants. UK pharmaceutical giant GSK says it will pay as ...
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 …
WEB1 day ago · Advertisement. (Reuters) -GSK has agreed to pay up to $2.2 billion to settle most pending U.S. state court lawsuits claiming that a discontinued version of the heartburn drug Zantac caused cancer ...
British pharma giant GSK strikes $2.3 billion deal to put an end to ...
WEB1 day ago · Vivian Wan/Bloomberg via Getty Images British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac ...
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits ...
WEB1 day ago · Oct 9, 2024 6:09pm. By Cristina Gallardo. GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine ...
FDA Requests Removal of All Ranitidine Products (Zantac) from …
WEBThe U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.